Biosistemak Institute for Health Systems Research
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer
Role: lead
Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients
Role: lead
Clinical Deterioration Early Warning System Score
Role: collaborator
Health Promotion Community-based Intervention Among Elderly People Through Self-managed MAHA Mobile App.
Role: lead
Universal Preventive Resilience Intervention to Improve and Promote Mental Health for Teenagers
Role: lead
A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy
Role: collaborator
All 6 trials loaded